Tony Chen
Founder & Chief Executive Officer Phrontline Biopharma
Seminars
Monday 12th October 2026
Spotlighting Branched Dual Payload Linker Design to Enable One-Step Conjugation to Bispecific Antibodies
2:30 pm
- Designing a branched linker–payload architecture that incorporates two distinct payloads into a single, preassembled conjugation moiety
- Enabling one-step attachment of the branched dual payload construct to a bispecific antibody, simplifying the generation of dual payload bispecific ADCs
- Demonstrating the approach through the preclinical profile of TJ102 and its recent IND clearance
